Neogen
NEOG
#5462
Rank
A$1.95 B
Marketcap
A$9.00
Share price
0.84%
Change (1 day)
-53.06%
Change (1 year)

Revenue for Neogen (NEOG)

Revenue in 2025 (TTM): A$1.37 Billion

According to Neogen's latest financial reports the company's current revenue (TTM ) is A$1.33 Billion. In 2024 the company made a revenue of A$1.46 Billion an increase over the revenue in the year 2023 that were of A$1.34 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Neogen from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) A$1.37 B-6.08%
2024 A$1.46 B8.96%
2023 A$1.34 B45.49%
2022 A$0.92 B33.6%
2021 A$0.69 B23.12%
2020 A$0.56 B-5.32%
2019 A$0.59 B2.03%
2018 A$0.58 B19.17%
2017 A$0.48 B3.42%
2016 A$0.47 B14.36%
2015 A$0.41 B27.66%
2014 A$0.32 B28.4%
2013 A$0.25 B35.3%
2012 A$0.18 B8.46%
2011 A$0.17 B9.39%
2010 A$0.15 B11.84%
2009 A$0.14 B-11.64%
2008 A$0.15 B48.27%
2007 A$0.10 B6.03%
2006 A$0.10 B13.19%
2005 A$89.44 M10.99%
2004 A$80.58 M22%
2003 A$66.05 M-15.11%
2002 A$77.8 M3.97%
2001 A$74.83 M40.04%
2000 A$53.44 M64.87%
1999 A$32.41 M-4.58%
1998 A$33.97 M34.13%
1997 A$25.32 M42.69%
1996 A$17.74 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
PerkinElmer
PKI
A$5.05 B 278.57%๐Ÿ‡บ๐Ÿ‡ธ USA
IDEXX Laboratories
IDXX
A$6.27 B 369.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$6.45 B 383.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacific Biosciences
PACB
A$0.23 B-82.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO
A$0.50 B-62.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$65.84 B 4,831.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
A$36.53 B 2,636.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
A$32.19 B 2,311.36%๐Ÿ‡บ๐Ÿ‡ธ USA